#318 Tranexamic Acid – Golden in the golden hours of trauma?
CLINICAL QUESTION
Does Tranexamic acid (TXA) in general adult trauma or traumatic head injuries improve mortality or disability without increased risk of adverse events?
BOTTOM LINE
Giving TXA to adult trauma patients within 3 hours of injury reduces overall mortality from 16% with placebo to 14.5% at 28 days. Giving TXA to isolated head injury patients within 3 hours decreases head injury death in patients with Glasgow Coma Scale (GCS) >3 (from 14% with placebo to 12.5%), largely driven by improvements in patients with GCS 9-15. Serious adverse events were similar to placebo.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
- Two large randomized, placebo-controlled trials of intravenous TXA (1g over 10 minutes, then 1 g over 8 hours) in adult trauma. Patients >80% male, median age 35-42 years. Outcomes at 28 days.
- General trauma: 20,211 patients with signs of shock or risk of significant hemorrhage, presenting within 8 hours of injury. 31% had co-existing head injury.1,2
- All-cause mortality: 14.5% versus 16% placebo; number needed to treat (NNT)=67.
- Only treatment ≤3 hours improved mortality (treatment >3 hours: No difference).
- Adverse events: Vascular occlusive event (myocardial infarction, stroke, pulmonary embolism) 1.7% versus 2.0% placebo, not statistically different.
- All-cause mortality: 14.5% versus 16% placebo; number needed to treat (NNT)=67.
- Traumatic brain injury: 12,737 patients with GCS of ≤12 or intracranial bleeding on CT and no major extracranial bleeding.3,4 Allowable time post-injury changed from 8 to ≤3 hours during study. Outcomes [for patients presenting ≤3 hours (N=9202)]:
- All-cause mortality: No difference.
- Head injury mortality (overall): No difference.
- Analyzed by severity of head injury (some pre-specified):
- Excluding GCS=3: 12.5% versus 14% placebo NNT=67.
- GCS 4-8 no difference.
- GCS 9-15: 5.8% versus 7.5% placebo NNT=59.
- Disability scores similar between groups.
- Adverse events: No difference.
- Limitation: No statistical correction for multiple sub-group analyses.
- Analyzed by severity of head injury (some pre-specified):
- Systematic reviews5,6 dominated by above studies found similar outcomes.
CONTEXT
- Hemorrhage causes 20-45% of trauma deaths.7,8,9
- Guidelines recommend using TXA within 3 hours in :
- "Severely injured bleeding patients."10
- "Patients with major trauma and active or suspected bleeding."11
- Pre-hospital TXA did not improve:
- Mortality in general trauma.12
- Neurological outcomes in traumatic brain injury patients.13
Latest Tools for Practice
#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy
How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
Thanks!
minimal benefit with TXA
Almost a 10% relative increase in survival. It’s worth it.